LONG MINI-FUTURE - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU12MZ6

Market Closed - Deutsche Boerse AG 11:13:56 05/07/2024 pm IST
10.15 EUR +2.94% Intraday chart for LONG MINI-FUTURE - FRESENIUS MEDICAL CARE
Current month+3.78%
1 month-23.97%
Date Price Change
05/24/05 10.15 +2.94%
04/24/04 9.86 +2.49%
03/24/03 9.62 -0.72%
02/24/02 9.69 -2.42%
01/24/01 9.93 +1.53%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 11:13 pm IST

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU12MZ
ISINDE000VU12MZ6
Date issued 11/01/2023
Strike 26.04
Maturity Unlimited
Parity 1 : 1
Emission price 7.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 24.33
Lowest since issue 5.24

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus